Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Luxfer Holdings PLCNYSE: LXFR
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA declines year over year
Q1 FY2026 EBITDA of $8.9M fell 21.2% year over year, ahead of the -25.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 53.4% from the prior quarter. Over 3 fiscal years it compounded at -15.4% a year.
Context
- EBITDA amounted to 9.9% of revenue in FY2025, down 1.6 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $44.15M (+15.9%) for the fiscal year ending Dec 2026, a step up from the -15.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $8.9M+53.4% QoQ
- Last fiscal yearDec 2025
- $38.1M-15.5% YoY
- LTMMar 2026
- $35.7M-25.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -21.2% | +14.4% | +35.7 pp |
| 1 year | -15.5% | +15.9% | +31.4 pp |
| 3-year CAGR | -15.4% | +6.0% | +21.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 38.1M USD
- Year-over-year change
- -15.5%
- 4-year CAGR
- -8.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 38.1M | -15.5% |
| FY2024 | 2024-12-31 | 45.1M | +257.9% |
| FY2023 | 2023-12-31 | 12.6M | -80.0% |
| FY2022 | 2022-12-31 | 62.9M | +16.3% |
| FY2021 | 2021-12-31 | 54.1M | — |
EBITDA vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 EBITDA of $35.7M is the 6th highest of the 11 companies compared; the peer median is $47.28M.
- Its year-over-year change of -25.6% is the 10th highest of 11, against a peer median of +1.3%.
- EBITDA amounts to 9.6% of revenue for LXFR, versus a peer median of 12.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $227.82M | +21.4% | +2.0% | 61.2% | |
| LTM Mar 2026 | $197.9M | +904.6% | +6.2% | 12.8% | |
| LTM Mar 2026 | $105.4M | -12.7% | +11.8% | 6.5% | |
| LTM Mar 2026 | $104.26M | +45.2% | -14.2% | 15.3% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $72.43M | -10.7% | +42.0% | 42.8% |
| LTM Mar 2026 | $35.7M | -25.6% | -15.4% | 9.6% | |
| LTM Mar 2026 | $22.13M | +13.3% | +21.4% | 5.1% | |
| LTM Mar 2026 | $18.38M | -23.4% | -13.7% | 18.7% | |
| LTM Mar 2026 | -$3.18M | +92.7% | +19.2% | 0.2% | |
| LTM Mar 2026 | -$39.84M | -15.9% | -23.6% | 6.0% | |
| LTM Mar 2026 | -$1.29B | -956.4% | — | — | |
| Peer median (excluding LXFR) | $47.28M | +1.3% | +6.2% | 12.8% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 374.1M | 423.4M | 405M | 391.9M | 384.6M |
| Cost of Revenue | 278.1M | 328.4M | 328.4M | 306.2M | 295.4M |
| Gross Profit | 96M | 95M | 76.6M | 85.7M | 89.2M |
| Gross Margin | 25.7% | 22.4% | 18.9% | 21.9% | 23.2% |
| Research & Development | 3.9M | 4.9M | 4.6M | 4.4M | 4.3M |
| Selling, General & Admin | 47.3M | 43.1M | 48.7M | 48.1M | 49.1M |
| Operating Expenses | 59.8M | 50.2M | 72.4M | 55.6M | 53.4M |
| Depreciation & Amortization | 15.6M | 18M | 16M | 13.4M | 12.8M |
| EBITDA | 54.1M | 62.9M | 12.6M | 45.1M | 38.1M |
| EBITDA Margin | 14.5% | 14.9% | 3.1% | 11.5% | 9.9% |
| Operating Income | 36.2M | 44.8M | 4.2M | 30.1M | 35.8M |
| Operating Margin | 9.7% | 10.6% | 1.0% | 7.7% | 9.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.1M | 3.9M | 6.3M | 5.2M | 3.1M |
| Other Income / Expenses | (800K) | (3.8M) | (13.9M) | (3.6M) | (13.6M) |
| Income Before Tax | 35.4M | 41M | (9.7M) | 26.5M | 22.2M |
| Pre-Tax Margin | 9.5% | 9.7% | -2.4% | 6.8% | 5.8% |
| Income Tax Expense | 5.4M | 9M | (7.1M) | 8.2M | 9.1M |
| Net Income | 29.9M | 26.9M | (1.9M) | 18.4M | 7.7M |
| Net Margin | 8.0% | 6.4% | -0.5% | 4.7% | 2.0% |
| EPS (Basic) | 1.08 | 0.99 | (0.07) | 0.69 | 0.29 |
| EPS (Diluted) | 1.07 | 0.98 | (0.07) | 0.69 | 0.28 |
| Weighted Avg Shares | 27.7M | 27.3M | 26.9M | 26.81M | 26.73M |
| Weighted Avg Shares (Diluted) | 28.03M | 27.54M | 27.02M | 26.81M | 27.25M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.